Clinical Trial Update: Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the combination of paclitaxel, folic acid, and lometrexol in adults with locally advanced or metastatic solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Lometrexol (Lometrexol)
• PACLITAXEL (PACLITAXEL)
• folic acid (folic acid)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: UNKNOWN